Monitoring the impact of vaccines postlicensure: new challenges, new opportunities

References

• CDC. Achievements in Public Health, 1900–1999. Impact of vaccines universally recommended for children – United States, 1990–1998. MMWR Morb. Mortal. Wkly Rep.48(12), 243–248 (1999).
   PubMedGoogle Scholar
• Roush SW, Murphy TV; Vaccine-Preventable Disease Table Working Group. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA298(18), 2155–2163 (2007).
   PubMed Web of Science ®Google Scholar
• Postila V, Kilpe T. Use of vaccine surveillance data in monitoring the safety of vaccines. Vaccine22, 2076–2079 (2004).
   PubMed Web of Science ®Google Scholar
• CDC. Update: multistate outbreak of mumps – United States, January 1–May 2, 2006 MMWR Morb. Mortal. Wkly Rep.55(20), 559–563 (2006).
   PubMedGoogle Scholar
• Dowdle WR, Hopkins DR. The Eradication of Infectious Diseases. John Wiley & Sons, Berlin, Germany (1998).
   Google Scholar
• CDC. Recommendations of the International Task Force for Disease Eradication. MMWR Morb. Mortal. Wkly Rep.42(RR-16), 1–38 (1993).
   PubMedGoogle Scholar
• Farizo KM, Strebel PM, Chen RT, Kimbler A, Cleary TJ, Cochi SL. Fatal respiratory disease due to Corynebacterium diphtheriae: case report and review of guidelines for management, investigation, and control. Clin. Infect. Dis.16(1), 59–68 (1993).
   PubMedGoogle Scholar
• Bilukha OO, Rosenstein N. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb. Mortal. Wkly Rep.54(RR 07), 1–21 (2005).
   PubMedGoogle Scholar
• Novak R, Williams IT, Bell BP. Update. Prevention of hepatitis A after exposure to hepatitis A virus and in international travelers. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb. Mortal. Wkly Rep.56, 1080–1084 (2007).
   PubMedGoogle Scholar
• McNabb SJN, Jajosky RA, Hall-Baker PA et al. Summary of notifiable diseases – United States, 2006. MMWR Morb. Mortal. Wkly Rep.55(53), 2–94 (2008).
   Google Scholar
• Liese JG, Grote G, Rosenfeld E et al. The burden of varicella complications before the introduction of routine varicella vaccination in Germany. Pediatr. Infect. Dis. J.27, 119–124 (2008).
   PubMed Web of Science ®Google Scholar
• Schuchat A, Hilger T, Zell E et al. Active bacterial core surveillance of the Emerging Infections Program Network. Emerg. Infect. Dis.7(1), 92–99 (2001).
   PubMed Web of Science ®Google Scholar
• Whitney CG, Farley MM, Hadler J et al. Decline in invasive pneumococcal disease after the introduction of protein–polysaccharide conjugate vaccine. N. Engl. J. Med.348, 1737–1746 (2003).
   PubMed Web of Science ®Google Scholar
• Lingappa JR, Rosenstein N, Zell ER et al. Surveillance for meningococcal disease and strategies for use of conjugate meningococcal vaccines in the United States. Vaccine19(31), 4566–4575 (2001).
   PubMedGoogle Scholar
• Bell BP, Shapiro CN, Alter MJ et al. The diverse patterns of hepatitis A epidemiology in the United States. Implications for vaccination strategies. J. Infect. Dis.178, 1579–1584 (1998).
   PubMed Web of Science ®Google Scholar
• Alter MJ, Hadler SC, Margolis HS et al. The changing epidemiology of hepatitis B in the United States: need for alternative vaccination strategies. J. Am. Med. Assoc.263, 1218–1222 (1990).
   PubMed Web of Science ®Google Scholar
• CDC. Update. Influenza activity – United States. September 30–December 1, 2007. MMWR Morb. Mortal. Wkly Rep.56, 1287–1291 (2007).
   PubMedGoogle Scholar
• Schrag SJ, Zell ER, Schuchat A, Whitney CG. Sentinel surveillance: a reliable way to track resistance in communities? Emerg. Infect. Dis.8(5), 496–502 (2002).
   PubMed Web of Science ®Google Scholar
• Broome CV, Facklam RR, Allen JR, Fraser DW. Epidemiology of pneumococcal serotypes in the United States, 1978–1979. J. Infect. Dis.141(1), 119–123 (1980).
   PubMed Web of Science ®Google Scholar
• CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007 MMWR Morb. Mortal. Wkly Rep.56(RR06), 1–54 (2007).
   PubMedGoogle Scholar
• Broome CV, Facklam RR, Fraser DW. Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine. N. Engl. J. Med.303(10), 549–552 (1980).
   PubMed Web of Science ®Google Scholar
• Bresee JS, Hummelman E, Nelson EA, Glass RI. Rotavirus in Asia: the value of surveillance for informing decisions about the introduction of new vaccines. J. Infect. Dis.192(Suppl. 1), S1–S5 (2005).
   PubMed Web of Science ®Google Scholar
• Bhat N, Wright JG, Broder KR et al. Influenza-associated deaths among children in the United States, 2003–2004. N. Engl. J. Med.353, 2559–2567 (2005).
   PubMed Web of Science ®Google Scholar
• Singleton R, Hammitt L, Hennessy T et al. The Alaska Haemophilus influenzae type b experience: lessons in controlling a vaccine-preventable disease. Pediatrics118(2), e421–e429 (2006).
   PubMed Web of Science ®Google Scholar
• Galil K, Singleton R, Levine OS et al. Reemergence of invasive Haemophilus influenzae type b disease in a well-vaccinated population in remote Alaska. J. Infect. Dis.179(1), 101–106 (1999).
   PubMed Web of Science ®Google Scholar
• Fry AM, Lurie P, Gidley M et al. Haemophilus influenzae type b disease among Amish children in Pennsylvania: reasons for persistent disease. Pediatrics108(4), E60 (2001).
   PubMedGoogle Scholar
• Parker AA, Staggs W, Dayan GH et al. Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States. N. Engl. J. Med.355(5), 447–455 (2006).
   PubMed Web of Science ®Google Scholar
• Markowitz LE, Preblud SR, Orenstein WA et al. Patterns of transmission in measles outbreaks in the United States, 1985–1986. N. Engl. J. Med.320(2), 75–81 (1989).
   PubMed Web of Science ®Google Scholar
• Orenstein WA. The role of measles elimination in development of a national immunization program. Pediatr. Infect. Dis. J.25(12), 1093–1101 (2006).
   PubMed Web of Science ®Google Scholar
• Chaves SS, Gargiullo P, Zhang JX et al. Loss of vaccine-induced immunity to varicella over time. N. Engl. J. Med.356(11), 1121–1129 (2007).
   PubMed Web of Science ®Google Scholar
• Marin M, Güris D, Chaves SS, Schmid S, Seward JF. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices. MMWR Morb. Mortal. Wkly Rep.56(RR04), 1–40 (2007).
   PubMedGoogle Scholar
• CDC. Acute flaccid paralysis surveillance systems for expansion to other diseases, 2003–2004. MMWR Morb. Mortal. Wkly Rep.53(47), 1113–1116 (2004).
   PubMedGoogle Scholar
• CDC. Progress toward interruption of wild poliovirus transmission – worldwide, January 2006–May 2007. MMWR Morb. Mortal. Wkly Rep.56(27), 682–685 (2007).
   PubMedGoogle Scholar
• CDC. Progress toward poliomyelitis eradication – India, January 2006–September 2007. MMWR Morb. Mortal. Wkly Rep.56(45), 1187–1191 (2007).
   PubMedGoogle Scholar
• Grassly NC, Wenger J, Durrani S et al. Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case–control study. Lancet369, 1356–1362 (2007).
   PubMed Web of Science ®Google Scholar
• CDC. Progress toward poliomyelitis eradication – Nigeria, 2005–2006. MMWR Morb. Mortal. Wkly Rep.56(12), 278–281 (2007).
   PubMedGoogle Scholar
• Whitney CG, Pilishvili T, Farley MM et al. Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case–control study. Lancet368(9546), 1495–1502 (2006).
   PubMed Web of Science ®Google Scholar
• Adams WG, Deaver KA, Cochi SL et al. Decline of childhood Haemophilus influenzae type b disease in the Hib vaccine era. J. Am. Med. Assoc.269, 221–226 (1993).
   PubMed Web of Science ®Google Scholar
• CDC. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease – United States, 1998–2003 MMWR Morb. Mortal. Wkly Rep.54(36), 893–897 (2005).
   PubMedGoogle Scholar
• Samandari T, Bell BP, Armstrong GA. Quantifying the impact of hepatitis A immunization in the United States, 1995–2001. Vaccine22, 4342–4350 (2004).
   PubMed Web of Science ®Google Scholar
• Chen RT, Hardy IR, Rhodes PH, Tyshchenko DK, Moiseeva AV, Marievsky VF. Ukraine, 1992: first assessment of diphtheria vaccine effectiveness during the recent resurgence of diphtheria in the former Soviet Union. J. Infect. Dis.181(Suppl. 1), S178–S183 (2000).
   PubMedGoogle Scholar
• Bisgard KM, Rhodes P, Hardy IR et al. Diphtheria toxoid vaccine effectiveness: a case–control study in Russia. J. Infect. Dis.181(Suppl. 1), S184–S187 (2000).
   PubMedGoogle Scholar
• Nathanson N, Langmuir AD. The Cutter incident. Poliomyelitis following formaldehyde-inactivated poliovirus vaccination in the United States during the spring of 1955. II. Relationship of poliomyelitis to Cutter vaccine. 1963. Am. J. Epidemiol.142(2), 109–140 (1995).
   PubMed Web of Science ®Google Scholar
• Orenstein WA, Bernier RH, Dondero TJ et al. Field evaluation of vaccine efficacy. Bull. World Health Organ.63, 1055–1068 (1985).
   PubMed Web of Science ®Google Scholar
• Trotter CL, Andrews NJ, Kaczmarski EB, Miller E, Ramsay ME. Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet364(9431), 365–367 (2004).
   PubMed Web of Science ®Google Scholar
• Marin M, Nguyen HQ, Langdrik JR et al. Measles transmission and vaccine effectiveness during a large outbreak on a densely populated island: implications for vaccine policy. Clin. Infect. Dis.42, 315–319 (2006).
   PubMed Web of Science ®Google Scholar
• Wenger JD, Pierce R, Deaver K, Plikaytis BD, Facklam RR, Broome CV. Efficacy of Haemophilus influenzae type b polysaccharide–diphtheria toxoid conjugate vaccine in US children aged 18–59 months. Lancet338, 395–398 (1991).
   PubMedGoogle Scholar
• Mills OF, Rhoads GG. The contribution of the case-control approach to vaccine evaluation: pneumococcal and Haemophilus influenzae type b PRP vaccines. J. Clin. Epidemiol.49(6), 631–636 (1996).
   PubMedGoogle Scholar
• Reingold AL, Broome CV, Hightower A et al. Age-specific differences in duration of clinical protection after vaccination with meningococcal polysaccharide A vaccine. Lancet2, 114–118 (1985).
   PubMed Web of Science ®Google Scholar
• CDC. Pertussis – United States, 2001–2003. MMWR Morb. Mortal. Wkly Rep.54(50), 1283–1286 (2005).
   PubMedGoogle Scholar
• Cohen C, White JM, Savage EJ et al. Vaccine effectiveness estimates, 2004–2005 mumps outbreak, England. Emerg. Infect. Dis.13(1), 12–17 (2007).
   PubMed Web of Science ®Google Scholar
• Takala AK, Eskola J, Leinonen M et al. Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. J. Infect. Dis.164, 982–986 (1991).
   PubMed Web of Science ®Google Scholar
• Mohle-Boetani JC, Ajello G, Breneman E et al. Carriage of Haemophilus influenzae type b in children after widespread vaccination with conjugate Haemophilus influenzae type b vaccines. Pediatr. Infect. Dis. J.12, 589–593 (1993).
   PubMed Web of Science ®Google Scholar
• Murphy TV, Pastor P, Medley F, Osterholm MT, Granoff DM. Decreased Haemophilus colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccine. J. Pediatr.122, 517–523 (1993).
   PubMed Web of Science ®Google Scholar
• O’Brien KL, Millar EV, Zell ER et al. Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community-randomized trial. J. Infect. Dis.196, 1211–1220 (2007).
   PubMed Web of Science ®Google Scholar
• Seward JF, Watson BF, Peterson CL et al. Varicella disease after introduction of varicella vaccine in the United States, 1995–2000. JAMA287, 606–611 (2002).
   PubMed Web of Science ®Google Scholar
• Wasley A, Samandari T, Bell BP. Hepatitis A in the United States in the era of vaccination. JAMA294, 194–201 (2005).
   PubMed Web of Science ®Google Scholar
• Trotter CL, Ramsay ME, Slack MP. Rising incidence of Haemophilus influenzae type b disease in England and Wales indicates a need for a second catch-up vaccination campaign. Commun. Dis. Public Health6(1), 55–58 (2003).
   PubMedGoogle Scholar
• CDC. Prevention of hepatitis A through active or passive immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb. Mortal. Wkly Rep.48(RR-12), 1–38 (1999).
   PubMedGoogle Scholar
• CDC. Prevention of hepatitis A through active or passive immunization. Recommendations of the Advisory Committee on Immunization Practices. MMWR Morb. Mortal. Wkly Rep.55(RR-7), 1–23 (2006).
   PubMedGoogle Scholar
• Atkinson WL, Hadler SC, Redd SB, Orenstein WA. Measles surveillance – United States, 1991. MMWR Surveill. Summ.41, 1–12 (1992).
   Google Scholar
• CDC. Interim Recommendations for the use of Haemophilus influenzae type b (Hib) conjugate vaccines related to the recall of certain lots of Hib-containing vaccines (PedvaxHIB® and Comvax®). MMWR Morb. Mortal. Wkly Rep.56(50), 1318–1320 (2007).
   PubMedGoogle Scholar
• Rodewald LE, Orenstein WA, Mason DD, Cochi SL. Vaccine supply problems: a perspective of the Centers for Disease Control and Prevention. Clin. Infect. Dis.42(Suppl. 3), S104–S110 (2006).
   PubMed Web of Science ®Google Scholar
• CDC. Updated Recommendations on the use of pneumococcal conjugate vaccine: suspension of recommendation for third and fourth dose. MMWR Morb. Mortal. Wkly Rep.53(08), 177–178 (2004).
   PubMedGoogle Scholar
• Adegbola RA, Secka O, Lahai G et al. Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study. Lancet366(9480), 144–150 (2005).
   PubMed Web of Science ®Google Scholar
• Flannery B, Schrag S, Bennett NM et al. Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections. JAMA291(18), 2197–2203 (2004).
   PubMedGoogle Scholar
• Bialek SR, Thoroughman DA, Hu D et al. Hepatitis A incidence and hepatitis A vaccination among American Indians and Alaska Natives, 1990–2001. Am. J. Public Health94, 996–1001 (2004).
   PubMed Web of Science ®Google Scholar
• Shepard CW, Finelli L, Fiore AE, Bell BP. Epidemiology of hepatitis B and hepatitis B virus infection in United States children. Pediatr. Infect. Dis. J.24(9), 755–760 (2005).
   PubMed Web of Science ®Google Scholar
• Luman E, Ching PM, Jumaan AO, Seward JF. Uptake of varicella vaccination among young children in the United States: a success story in eliminating racial and ethnic disparities. Pediatrics117, 999–1008 (2006).
   PubMedGoogle Scholar
• Feikin DR, Lezotte DC, Hamman RF, Salmon DA, Chen RT, Hoffman RE. Individual and community risks of measles and pertussis associated with personal exemptions to immunization. JAMA284(24), 3145–3150 (2000).
   PubMed Web of Science ®Google Scholar
• Omer SB, Pan WK, Halsey NA et al. Nonmedical exemptions to school immunization requirements: secular trends and association of state policies with pertussis incidence. JAMA296(14), 1757–1763 (2006).
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control. Serotyping discrepancies in Haemophilus influenzae type b disease – United States, 1998–1999. MMWR Morb. Mortal. Wkly Rep.51(32), 706–707 (2002).
   PubMedGoogle Scholar
• Traoré Y, Njanpop-Lafourcade BM, Adjogble KL et al. The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, 2002–2005. Clin. Infect. Dis.43(7), 817–822 (2006).
   PubMed Web of Science ®Google Scholar
• Hicks LA, Harrison LH, Flannery B et al. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998–2004. J. Infect. Dis.196(9), 1346–1354 (2007).
   PubMed Web of Science ®Google Scholar
• Brueggemann AB, Pai R, Crook DW, Beall B. Vaccine escape recombinants emerge after pneumococcal vaccination in the United States. PLoS Pathog.3(11), e168 (2007).
   PubMed Web of Science ®Google Scholar
• Kew OM, Sutter RW, de Gourville EM, Dowdle WR, Pallansch MA. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu. Rev. Microbiol.59, 587–635 (2005).
   PubMed Web of Science ®Google Scholar
• CDC. Update on vaccine-derived polioviruses – worldwide, January 2006–August 2007. MMWR Morb. Mortal. Wkly Rep.56(38), 996–1001 (2007).
   PubMedGoogle Scholar
• Rota PA, Liffick SL, Rota JS et al. Molecular epidemiology of measles viruses in the United States, 1997–2001. Emerg. Infect. Dis.8(9), 902–908 (2002).
   PubMedGoogle Scholar
• Nainan OV, Armstrong GL, Han XH, Williams I, Bell BP, Margolis HS. Hepatitis A molecular epidemiology in the United States, 1996–1997: sources of infection and implications of vaccination policy. J. Infect. Dis.191(6), 957–963 (2005).
   PubMedGoogle Scholar
• Kyaw MH, Lynfield R, Schaffner W et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N. Engl. J. Med.354(14), 1455–1463 (2006).
   PubMed Web of Science ®Google Scholar
• Bright RA, Shay DK, Shu B, Cox NJ, Klimov AI. Adamantane resistance among influenza A viruses isolated early during the 2005–2006 influenza season in the United States. JAMA295(8), 891–894 (2006).
   PubMed Web of Science ®Google Scholar
• Rosenstein NE, Stocker SA, Popovic T, Tenover FC, Perkins BA. Antimicrobial resistance of Neisseria meningitidis in the United States, 1997. Clin. Infect. Dis.30(1), 212–213 (2000).
   PubMedGoogle Scholar
• CDC. Progress in global measles control and mortality reduction, 2000–2006. MMWR Morb. Mortal. Wkly Rep.56(47), 1237–1241 (2007).
   PubMedGoogle Scholar
• CDC. Progress in hepatitis B prevention through universal infant vaccination – China, 1997–2006. MMWR Morb. Mortal. Wkly Rep.56(18), 441–415 (2007).
   PubMedGoogle Scholar
• CDC. Global progress toward universal childhood hepatitis B vaccination, 2003. MMWR Morb. Mortal. Wkly Rep.52, 868–870 (2003).
   PubMedGoogle Scholar
• Milstien JB, Kaddar M, Kieny MP. The impact of globalization on vaccine development and availability. Health Aff. (Millwood)25(4), 1061–1069 (2006).
   PubMed Web of Science ®Google Scholar
• Henderson DA. Countering the posteradication threat of smallpox and polio. Clin. Infect. Dis.34(1), 79–83 (2002).
   PubMedGoogle Scholar
• Grijalva CG, Weinberg GA, Bennett NM et al. Estimating the undetected burden of influenza hospitalizations in children. Epidemiol. Infect.135(6), 951–958 (2007).
   PubMed Web of Science ®Google Scholar
• Schrag SJ, Shay DK, Gershman K et al.; Emerging Infections Program Respiratory Diseases Activity. Multistate surveillance for laboratory-confirmed, influenza-associated hospitalizations in children: 2003–2004. Pediatr. Infect. Dis. J.25(5), 395–400 (2006).
   PubMed Web of Science ®Google Scholar
• Griffin MR, Walker FJ, Iwane MK et al. Epidemiology of respiratory infections in young children: insights from the new vaccine surveillance network. Pediatr. Infect. Dis. J.23(11 Suppl.), S188–S192 (2004).
   PubMedGoogle Scholar
• Davis RL, Kolczak M, Lewis E et al. Active surveillance of vaccine safety: a system to detect early signs of adverse events. Epidemiology16, 336–341 (2005).
   PubMed Web of Science ®Google Scholar
• Nichol KL, Nordin JD, Nelson DB, Mullooly JP, Hak E. Effectiveness of influenza vaccine in the community-dwelling elderly. N. Engl. J. Med.357, 1373–1381 (2007).
   PubMed Web of Science ®Google Scholar
• Mell LK, Davis RL, Mullooly JP et al. Polio extraimmunization in children younger than 2 years after changes in immunization recommendations. Pediatrics111, 296–301 (2003).
   PubMedGoogle Scholar
• CDC. Outbreaks of respiratory illness mistakenly attributed to pertussis – New Hampshire, Massachusetts, and Tennessee, 2004–2006. MMWR Morb. Mortal. Wkly Rep.56(33), 837–842 (2007).
   PubMedGoogle Scholar
• Freeman VA, DeFriese GH. The challenge and potential of childhood immunization registries. Ann. Rev. Public Health24, 227–246 (2003).
   PubMedGoogle Scholar
• Canavan BC, Kurilo M, Moss T et al. Immunization information systems progress – United States, 2005. MMWR Morb. Mortal. Wkly Rep.55(49), 1327–1329 (2006).
   PubMedGoogle Scholar
• CDC. Influenza vaccination coverage among children aged 6–59 months – six immunization information system sentinel sites, United States, 2006–07 influenza season. MMWR Morb. Mortal. Wkly Rep.56(37), 963–965 (2007).
   PubMedGoogle Scholar
• CDC. Withdrawal of rotavirus vaccine recommendation. MMWR Morb. Mortal. Wkly Rep.48(43), 1007 (1999).
   PubMedGoogle Scholar
• Murphy TV, Gargiullo PM, Massoudi MS et al. Intussusception among infants given an oral rotavirus vaccine. N. Engl. J. Med.344(8), 564–572 (2001).
   PubMed Web of Science ®Google Scholar
• Vesikari T, Matson DO, Dennehy P et al. Safety and efficacy of a pentavalent human–bovine (WC3) reassortant rotavirus vaccine. N. Engl. J. Med.354(1), 23–33 (2006).
   PubMed Web of Science ®Google Scholar
• Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N. Engl. J. Med.354(1), 11–22 (2006).
   PubMed Web of Science ®Google Scholar
• CDC. Post-marketing monitoring of intussception after RotaTeq vaccination—United States, February 1, 2006–February 15, 2007. MMWR Morb. Mortal. Wkly Rep.56, 218–222 (2007).
   PubMedGoogle Scholar
• Kempe A, Daley MF, Parashar UD et al. Will pediatricians adopt the new rotavirus vaccine? Pediatrics119, 1–10 (2007).
   PubMedGoogle Scholar
• Herrera GA, Iwane MK, Cortese M et al. Influenza vaccination effectiveness among 50–64 year old persons during a season of poor antigenic match between vaccine and circulating influenza virus strains: Colorado, United States, 2003–2004. Vaccine25, 154–160 (2007).
   PubMed Web of Science ®Google Scholar
• Szilagyi PG, Fairbrother G, Griffin MR et al. Influenza vaccine effectiveness among children 6 to 59 months of age during two influenza seasons: a case–cohort study. Arch. Pediatr. Adolesc. Med. (2008) (In press).
   Google Scholar
• Simonsen L, Viboud C , Taylor RJ. Effectiveness of influenza vaccination. N. Engl. J. Med.357, 2729–2730 (2007).
   PubMedGoogle Scholar
• Jackson LA, Jackson ML, Nelson JC, Neuzil KM, Weiss NS. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int. J. Epidemiol.35, 337–344 (2006).
   PubMed Web of Science ®Google Scholar
• CDC. Progress in global measles control and mortality reduction, 2000–2006. MMWR Morb. Mortal. Wkly Rep.56(47), 1237–1241 (2007).
   PubMedGoogle Scholar
• Dabbagh A, Eggers R, Cochi S, Dietz D, Strebel P, Cherian T. A new global framework for immunization monitoring and surveillance. Bull. World Health Organ.85(12), 904–905 (2007).
   PubMedGoogle Scholar
• Orenstein WA, Douglas RG, Rodewald LE, Hinman AR. Immunizations in the United States: success, structure, and stress. Health Affairs24, 599–610 (2005).
   PubMed Web of Science ®Google Scholar